Emerging clinical role of ranolazine in the management of angina
David S Vadnais, Nanette K WengerDivision of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USAAbstract: Chronic stable angina is an exceedingly prevalent condition with tremendous clinical, social, and financial implications. Traditional medical therapy for angina consists of be...
Main Authors: | David S Vadnais, Nanette K Wenger |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-10-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/emerging-clinical-role-of-ranolazine-in-the-management-of-angina-a5511 |
Similar Items
-
Update on ranolazine in the management of angina
by: Codolosa JN, et al.
Published: (2014-06-01) -
Update on evidence for treatment with ranolazine in stable angina
by: Federico Carbone, et al.
Published: (2013-10-01) -
The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
by: Simone Calcagno, et al.
Published: (2020-07-01) -
EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01) -
EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)